MOLECULAR PROFILING OF THE EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) PATHWAY IN THE MANAGEMENT OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS (PTS)

被引：0
|
作者：
Nuzzo, C. [1 ]
Sperduti, I. [2 ]
Marchetti, A. [3 ]
Cianciulli, A. M. [2 ]
Mottolese, M. [2 ]
Buttitta, F. [3 ]
Visca, P. [1 ]
Cecere, F. L. [4 ]
Cognetti, F. [1 ]
Milella, M. [1 ]
机构：
[1] Regina Elena Inst Canc Res, Rome, Italy
[2] Regina Elena Inst Canc Res, Rome, Italy
[3] Univ G dAnnunzio, Chieti, Italy
[4] IFO Regina Elena Natl, Div Med Oncol A, Rome, Italy
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：105 / 105
页数：1
相关论文
共 50 条
  • [41] Epidermal growth factor receptor in non-small cell lung cancer
    Prabhakar, Charles N.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2015, 4 (02) : 110 - 118
  • [42] Rebiopsy of patients (pts) with acquired resistance to epidermal growth factor tyrosine kinase inhibitors (EGFR-TKIs) in non-small cell lung cancer (NSCLC)
    Arcila, M. E.
    Riely, G. J.
    Zakowski, M. F.
    Kris, M. G.
    Ladanyi, M.
    Pao, W.
    Miller, V. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [43] Management of Acquired Resistance to Epidermal Growth Factor Receptor Kinase Inhibitors in Patients With Advanced Non-Small Cell Lung Cancer
    Sacher, Adrian G.
    Jaenne, Pasi A.
    Oxnard, Geoffrey R.
    CANCER, 2014, 120 (15) : 2289 - 2298
  • [44] Epidermal growth factor receptor (EGFR) gene amplification in non-small cell lung cancer (NSCLC): molecular patterns and sensitivity to tyrosine kinase inhibitors
    Skokan, Margaret C.
    Gajapathy, Sujatha
    Xiao, Yun
    Franklin, Wilbur A.
    Hirsch, Fred R.
    Bunn, Paul A., Jr.
    Varella-Garcia, Marileila
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S322 - S322
  • [45] Epidermal Growth Factor Receptor (EGFR)-Mediated Adverse Events (AEs) in Patients (pts) With EGFR-Mutation Positive (EGFR M plus ) Non-Small Cell Lung Cancer (NSCLC) Treated With Afatinib (A)
    Wu, Y.
    Geater, S. L.
    Mok, T.
    O'Byrne, K. J.
    Schuler, M. H.
    Sequist, L. V.
    Yang, J. C.
    Massey, D.
    O'Brien, D.
    Zazulina, V.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S41 - S41
  • [46] Epidermal growth factor receptor mutations in patients with non-small cell lung cancer
    Johnson, BE
    Jänne, PA
    CANCER RESEARCH, 2005, 65 (17) : 7525 - 7529
  • [47] The role of osimertinib in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer
    Liam, Chong-Kin
    JOURNAL OF THORACIC DISEASE, 2019, 11 : S448 - S452
  • [48] Multicenter prospective study of erlotinib in advanced non-small-cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations
    Cardenal, Felipe
    Moran, Teresa
    Queralt, Cristina
    Porta, Ruth
    Camps, Carlos
    Majem, Margarita
    Lopez-Vivanco, Guillermo
    Isla, Dolores
    Provencio, Mariano
    Sanchez, Jose Javier
    Taron, Miquel
    Rosell, Rafael
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S324 - S325
  • [49] A review of prognostic factors for patients with epidermal growth factor receptor mutation positive advanced non small cell lung cancer (EGFR plus NSCLC)
    Itotani, R.
    Marumo, S.
    Fukui, M.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S129 - S129
  • [50] Frequency and clinical correlations of epidermal growth factor receptor (EGFR) mutations in a large cohort of Italian non-small cell lung cancer (NSCLC) patients (pts) within the EGFR FASTnet program.
    Normanno, Nicola
    Pinto, Carmine
    Taddei, Gian Luigi
    Troncone, Giancarlo
    Graziano, Paolo
    De Maglio, Giovanna
    Mottolese, Marcella
    Ludovini, Vienna
    Zupo, Simonetta
    Larocca, Luigi Maria
    Roz, Elena
    Russo, Antonio
    Palmieri, Giuseppe
    Perrone, Giuseppe
    Di Maio, Massimo
    Ardizzoni, Andrea
    Crino, Lucio
    Perrone, Francesco
    Clemente, Claudio
    Marchetti, Antonio
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345